Source abstract
Abstract
High Resolution Image Download MS PowerPoint Slide Synthetic small-diameter vascular grafts (<6 mm) are used in the treatment of cardiovascular diseases, including coronary artery disease, but fail much more readily than similar grafts made from autologous vascular tissue. A promising approach to improve the patency rates of synthetic vascular grafts is to promote the adhesion of endothelial cells to the luminal surface of the graft. In this study, we characterized the surface chemical and topographic changes imparted on poly(vinyl alcohol) (PVA), an emerging hydrogel vascular graft material, after exposure to various reactive ion plasma (RIP) surface treatments, how these changes dissipate after storage in a sealed environment at standard temperature and pressure, and the effect of these changes on the adhesion of endothelial colony-forming cells (ECFCs). We showed that RIP treatments including O 2, N 2, or Ar at two radiofrequency powers, 50 and 100 W, improved ECFC adhesion compared to untreated PVA and to different degrees for each RIP treatment, but that the topographic and chemical changes responsible for the increased cell affinity dissipate in samples treated and allowed to age for 230 days. We characterized the effect of aging on RIP-treated PVA using an assay to quantify ECFCs on RIP-treated PVA 48 h after seeding, atomic force microscopy to probe surface topography, scanning electron microscopy to visualize surface modifications, and X-ray photoelectron spectroscopy to investigate surface chemistry. Our results show that after treatment at higher RF powers, the surface exhibits increased roughness and greater levels of charged nitrogen species across all precursor gases and that these surface modifications are beneficial for the attachment of ECFCs. This study is important for our understanding of the stability of surface modifications used to promote the adhesion of vascular cells such as ECFCs.
Source: openalex_inverted_index · Quality: baseline
Affiliations
School of Chemical, Biological, and Environmental Engineering, Oregon State University, 103 Gleeson Hall, Corvallis, Oregon 97331, United States
Biomedical Engineering Program, University of Colorado Boulder, 1111 Engineering Drive 521 UCB, Boulder, Colorado 80309-0521, United States
Department of Biomedical Engineering, Oregon Health and Science University, 3303 SW Bond Ave, Portland, Oregon 97239, United States
Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health and Science University, 3303 SW Bond Ave, Portland, Oregon 97239, United States
Department of Biomedical Engineering, San José State University, One Washington Square, San Jose, California 95112-3613, United States
Funding
National Heart, Lung, and Blood Institute · National Institute of Child Health and Human Development · Program for Education and Research in Biotechnology, California State University · National Institute of General Medical Sciences